Estados financieros detallados de BriaCell Therapeutics Corp. (BCTX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $3.56, BCTX presenta beneficios negativos (P/E no significativo) y un ROE del -147.92%. La capitalización bursátil es de $31M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $1803 | $290 | $16877 | $18833 | $18735 | $15580 | $15139 | $15529 | $82573 | $147888 |
| Beneficio Bruto | -$1803 | -$289 | -$16877 | -$18833 | -$18735 | -$15580 | -$15139 | -$15529 | -$82573 | -$147888 |
| I+D | $952150 | $2.1M | $3.1M | $4.9M | $3.0M | $2.5M | $10.3M | $20.5M | $27.2M | $29.5M |
| Generales y Administrativos | $1.2M | $1.1M | $1.8M | $1.3M | $1.8M | $6.2M | $9.3M | $10.6M | $6.2M | $8.1M |
| Gastos Operativos | $2.2M | $3.2M | $5.0M | $6.2M | $4.8M | $8.7M | $19.6M | $31.1M | $33.3M | $37.6M |
| Beneficio Operativo | -$2.2M | -$3.2M | -$5.0M | -$6.3M | -$5.3M | -$8.7M | -$19.6M | -$31.1M | -$33.3M | -$37.7M |
| EBITDA | -$2.2M | -$3.2M | -$5.4M | -$5.8M | -$4.8M | -$17.1M | -$34.4M | -$31.1M | -$4.8M | -$37.6M |
| Gastos por Intereses | 0 | 0 | $20344 | $31467 | $36204 | $100217 | $1244 | 0 | 0 | $51288 |
| Beneficio Antes de Impuestos | -$2.2M | -$3.2M | -$5.4M | -$5.8M | -$5.4M | -$17.3M | -$34.4M | -$27.1M | -$4.9M | -$36.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$2.2M | -$3.2M | -$5.4M | -$5.8M | -$4.9M | -$17.3M | -$34.4M | -$27.1M | -$4.8M | -$36.5M |
| BPA | $-1360.30 | $-1348.63 | $-1798.34 | $-1505.30 | $-5.64 | $-13.50 | $-257.58 | $-192.55 | $-43.01 | $-62.60 |
| BPA Diluido | $-1360.30 | $-1348.63 | $-1798.34 | $-1505.30 | $-5.64 | $-13.50 | $-259.50 | $-195.00 | $-43.01 | $-62.60 |
| Acciones en Circulación (Diluidas) | $19231 | $22647 | $28520 | $38644 | $47592 | $301305 | $1.0M | $1.0M | $1.1M | $1.9M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $131576 | $1.0M | $720259 | $157034 | $21249 | $71.6M | $52.6M | $28.4M | $1.2M | $14.4M |
| Inversiones a Corto | $689021 | $601757 | $1.0M | 0 | 0 | 0 | 0 | 0 | 0 | $10.1M |
| Cuentas por Cobrar | $2669 | $5601 | $14563 | $2816 | $22515 | $15714 | $30911 | $958562 | $1.9M | $776542 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $833345 | $1.6M | $1.9M | $168533 | $261463 | $72.2M | $54.3M | $36.0M | $5.1M | $27.4M |
| Inmovilizado Material | $449 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $538872 | $408099 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | $274733 | $276121 | $260866 | $306954 | $295404 | $287228 | $277360 | $253705 |
| Activos Totales | $835696 | $1.6M | $2.3M | $444656 | $522331 | $72.5M | $54.6M | $36.3M | $8.2M | $29.8M |
| Cuentas por Pagar | 0 | 0 | 0 | 0 | 0 | $267594 | $594145 | $1.5M | $10.0M | $4.5M |
| Deuda a Corto | 0 | 0 | $1.1M | $322526 | $249799 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $48591 | $885904 | $1.3M | $1.1M | $4.0M | $695862 | $1.2M | $2.4M | $10.4M | $5.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $32476 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $48591 | $885904 | $1.3M | $1.1M | $4.1M | $38.0M | $41.4M | $41.3M | $11.9M | $5.9M |
| Reservas | -$4.3M | -$6.7M | -$9.7M | -$14.7M | -$18.2M | -$36.4M | -$77.4M | -$107.7M | -$118.6M | -$153.7M |
| Patrimonio Neto | $787105 | $750232 | $945016 | -$688665 | -$3.6M | $34.6M | $13.2M | -$5.0M | -$3.3M | $24.6M |
| Deuda Total | 0 | 0 | $1.1M | $322526 | $249799 | $32476 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$820597 | -$1.6M | -$628854 | $165492 | $228550 | -$71.5M | -$52.6M | -$28.4M | -$1.2M | -$24.6M |
| Capital Circulante | $784754 | $748327 | $537519 | -$964788 | -$3.7M | $71.5M | $53.1M | $33.6M | -$5.3M | $21.9M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$2.2M | -$3.2M | -$5.4M | -$5.8M | -$4.9M | -$17.6M | -$34.1M | -$27.3M | -$6.5M | -$36.5M |
| Amortizaciones | $1803 | $290 | $16877 | $18833 | $18735 | $19462 | $19417 | $20508 | $114643 | $147893 |
| Compensación en Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cambio en Capital Circulante | -$28993 | $1.0M | -$466675 | $1.0M | $3.3M | -$2.9M | -$497542 | -$4.7M | $9.6M | -$2.6M |
| Flujo de Caja Operativo | -$1.6M | -$1.9M | -$5.0M | -$5.1M | -$1.6M | -$9.9M | -$15.9M | -$31.9M | -$33.0M | -$39.1M |
| Inversiones (CapEx) | $3 | $4 | $3 | -$5 | 0 | -$4 | 0 | $4 | -$624208 | $3 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | -$12.9M | -$63518 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$1.6M | -$1.9M | -$5.0M | -$5.1M | -$1.6M | -$9.9M | -$15.9M | -$31.9M | -$33.6M | -$39.1M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | -44.2% | -68.1% | -7.6% | +15.0% | -249.3% | -99.3% | +21.2% | +82.3% | -661.4% | |
| Crecimiento BPA (anual) | +0.9% | -33.3% | +16.3% | +99.6% | -139.4% | -1808.0% | +25.2% | +77.7% | -45.5% | |
| Cambio en Acciones (anual) | +17.8% | +25.9% | +35.5% | +23.2% | +533.1% | +242.8% | +0.8% | +5.3% | +71.7% | |
| Crecimiento FCF (anual) | -21.1% | -159.2% | -3.3% | +69.6% | -536.0% | -60.5% | -100.9% | -5.3% | -16.3% | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-82.07 | $-84.41 | $-173.70 | $-132.48 | $-32.67 | $-32.82 | $-15.37 | $-30.63 | $-30.62 | $-20.74 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $19231 | $22647 | $28520 | $38644 | $47592 | $301305 | $1.0M | $1.0M | $1.1M | $1.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -147.92% |
| Rentabilidad sobre capital invertido | -136.31% |
| Rentabilidad sobre activos | -113.23% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 7.07 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -7.34 | -5.66 | -3.28 | -1.89 | -256.55 | -56.44 | -3.73 | -5.21 | -2.62 | -0.12 |
| P/VC | 244.07 | 230.54 | 178.23 | -159.88 | -19.14 | 6.64 | 74.98 | -207.15 | -37.44 | 0.57 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ALLR · ASBP · CRIS · CTXR · ENTO · HOTH · LPTX
Explorar sector: Healthcare · Biotechnology
Más secciones de BCTX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones